CTX (C-terminal telopeptide)
A blood marker of bone resorption — how fast bone is being broken down. Its main use is in osteoporosis: measured before and during treatment, a fall in CTX shows that a bone-protecting medication is working.
What it measures
Bone is constantly being renewed: old bone is broken down (resorption) and new bone is laid down (formation), in a balance that shifts with age and health. CTX (C-terminal telopeptide of type I collagen, also called beta-CrossLaps) is a fragment released into the blood when the collagen framework of bone is broken down, so its level reflects the rate of bone resorption at that moment. It is one of the main 'bone turnover markers'. Its most established use is in osteoporosis treatment: many osteoporosis drugs (such as bisphosphonates) work by slowing bone breakdown, and a CTX measured before starting and again a few months later should fall substantially if the medication is working — providing an early check on treatment response and, sometimes, on whether a person is taking it. CTX is naturally higher after the menopause and in states of rapid bone turnover, and it can help assess how active bone loss is. Because CTX varies a lot with food and time of day, it is measured fasting and in the morning for consistency, and it is interpreted alongside calcium, vitamin D, PTH and alkaline phosphatase rather than in isolation.
What a high value can mean
- High bone turnover / rapid bone resorption — as after the menopause, or in untreated osteoporosis.
- Overactive parathyroid (hyperparathyroidism) or an overactive thyroid — drive bone breakdown.
- Paget's disease of bone — high bone turnover.
- Not yet responding to treatment — a CTX that has not fallen on an osteoporosis medication.
- Sampling effects — falsely higher if not measured fasting in the morning.
What a low value can mean
- A good treatment response — a low or fallen CTX on a bone-protecting medication suggests it is working.
- Low bone turnover — expected on effective anti-resorptive treatment.
When to discuss with a doctor
CTX is a specialist tool used mainly around osteoporosis treatment rather than as a general test. Its main value is monitoring: a CTX before starting a bone-protecting medication and again after a few months, with a clear fall, gives early reassurance that the treatment is working and being absorbed. A high CTX can also indicate rapid bone loss that supports a decision to treat. Because levels swing with food and time of day, it must be measured fasting in the morning, and it is always interpreted with calcium, vitamin D, PTH and alkaline phosphatase, and the bone-density (DEXA) result. It does not replace a bone-density scan for diagnosing osteoporosis. Mediora.AI shows CTX alongside calcium, vitamin D, PTH and alkaline phosphatase so the bone-turnover pattern is visible; the interpretation and any treatment decisions belong with your doctor.